A citation-based method for searching scientific literature


List of co-cited articles
82 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
66


Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
480
23


Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Antonio Abbate, Stefano Toldo, Carlo Marchetti, Jordana Kron, Benjamin W Van Tassell, Charles A Dinarello. Circ Res 2020
113
19

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
684
19


Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
14

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
Peter Libby, Joseph Loscalzo, Paul M Ridker, Michael E Farkouh, Priscilla Y Hsue, Valentin Fuster, Ahmed A Hasan, Salomon Amar. J Am Coll Cardiol 2018
208
14


Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
192
14

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
14

A role for mitochondria in NLRP3 inflammasome activation.
Rongbin Zhou, Amir S Yazdi, Philippe Menu, Jürg Tschopp. Nature 2011
14

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
988
14

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
Sarah L Westlake, Alexandra N Colebatch, Janis Baird, Patrick Kiely, Mark Quinn, Ernest Choy, Andrew J K Ostor, Christopher J Edwards. Rheumatology (Oxford) 2010
245
14

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
Hyon K Choi, Miguel A Hernán, John D Seeger, James M Robins, Frederick Wolfe. Lancet 2002
821
14

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
843
14

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
José J Fuster, Susan MacLauchlan, María A Zuriaga, Maya N Polackal, Allison C Ostriker, Raja Chakraborty, Chia-Ling Wu, Soichi Sano, Sujatha Muralidharan, Cristina Rius,[...]. Science 2017
517
14


Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
Antonio Naranjo, Tuulikki Sokka, Miguel A Descalzo, Jaime Calvo-Alén, Kim Hørslev-Petersen, Reijo K Luukkainen, Bernard Combe, Gerd R Burmester, Joe Devlin, Gianfranco Ferraccioli,[...]. Arthritis Res Ther 2008
308
14

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Camille Roubille, Vincent Richer, Tara Starnino, Collette McCourt, Alexandra McFarlane, Patrick Fleming, Stephanie Siu, John Kraft, Charles Lynde, Janet Pope,[...]. Ann Rheum Dis 2015
436
14


Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
180
9

Activation and regulation of the inflammasomes.
Eicke Latz, T Sam Xiao, Andrea Stutz. Nat Rev Immunol 2013
9

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
Paul M Ridker, Jean G MacFadyen, Robert J Glynn, Wolfgang Koenig, Peter Libby, Brendan M Everett, Martin Lefkowitz, Tom Thuren, Jan H Cornel. J Am Coll Cardiol 2018
85
9

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Gonzalo J Martínez, David S Celermajer, Sanjay Patel. Atherosclerosis 2018
103
9

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.
Ntobeko A B Ntusi, Jane M Francis, Emily Sever, Alexander Liu, Stefan K Piechnik, Vanessa M Ferreira, Paul M Matthews, Matthew D Robson, Paul B Wordsworth, Stefan Neubauer,[...]. Int J Cardiol 2018
22
9

The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.
Michael Nurmohamed, Ernest Choy, Sadiq Lula, Blerina Kola, Ryan DeMasi, Paola Accossato. Drug Saf 2018
19
10

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
Iain B McInnes, Liz Thompson, Jon T Giles, Joan M Bathon, Jane E Salmon, Andre D Beaulieu, Christine E Codding, Timothy H Carlson, Christian Delles, Janet S Lee,[...]. Ann Rheum Dis 2015
173
9


EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
R Agca, S C Heslinga, S Rollefstad, M Heslinga, I B McInnes, M J L Peters, T K Kvien, M Dougados, H Radner, F Atzeni,[...]. Ann Rheum Dis 2017
510
9

Vascular Smooth Muscle Cells in Atherosclerosis.
Martin R Bennett, Sanjay Sinha, Gary K Owens. Circ Res 2016
810
9

Macrophages in atherosclerosis: a dynamic balance.
Kathryn J Moore, Frederick J Sheedy, Edward A Fisher. Nat Rev Immunol 2013
9

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
9


Type 2 diabetes as an inflammatory disease.
Marc Y Donath, Steven E Shoelson. Nat Rev Immunol 2011
9


Anti-inflammatory therapies for cardiovascular disease.
Paul M Ridker, Thomas F Lüscher. Eur Heart J 2014
358
9

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Donna K Arnett, Roger S Blumenthal, Michelle A Albert, Andrew B Buroker, Zachary D Goldberger, Ellen J Hahn, Cheryl Dennison Himmelfarb, Amit Khera, Donald Lloyd-Jones, J William McEvoy,[...]. Circulation 2019
767
9

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.
P M Ridker, N Rifai, M Pfeffer, F Sacks, S Lepage, E Braunwald. Circulation 2000
714
9


Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.
Paul M Ridker, Campbell P Howard, Verena Walter, Brendan Everett, Peter Libby, Johannes Hensen, Tom Thuren. Circulation 2012
330
9

Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs.
Matteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, Raffaele Scarpa, Giovanni Di Minno. Arterioscler Thromb Vasc Biol 2011
94
9

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis.
Alexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, Jacqueline Capeau, Stéphanie Rouanet, Jean Sibilia, Philippe Ravaud, Francis Berenbaum, Jacques-Eric Gottenberg, Jérémie Sellam. RMD Open 2019
10
20


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
9


Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.
Brendan M Everett, Jan H Cornel, Mitja Lainscak, Stefan D Anker, Antonio Abbate, Tom Thuren, Peter Libby, Robert J Glynn, Paul M Ridker. Circulation 2019
184
9

C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.